Slawinski M, Grodzinska L, Kostka-Trabka E, Bieron K, Goszcz A, Gryglewski R J
Acta Physiol Hung. 1996;84(4):457-8.
Intravenous infusions of L-arginine (L-ARG) and placebo (saline) resulted in improvement of clinical assessments, statistically significant after L-ARG but not after saline. Results of laboratory estimations for platelet and fibrynolysis changed significantly following L-ARG infusions but not after infusions of placebo. These data indicate beneficial effects of L-ARG as a therapeutic agent in patients with peripheral arterial obliterative disease (PAOD). In these patients exogenous L-ARG can be converted to NO.
静脉输注L-精氨酸（L-ARG）和安慰剂（生理盐水）均使临床评估得到改善，L-ARG输注后具有统计学意义，而生理盐水输注后则无。L-ARG输注后血小板和纤维蛋白溶解的实验室评估结果发生显著变化，而安慰剂输注后则无。这些数据表明L-ARG作为治疗剂对周围动脉闭塞性疾病（PAOD）患者具有有益作用。在这些患者中，外源性L-ARG可转化为一氧化氮（NO）。
